+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antidiabetic"

Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 450 Pages
  • Global
From
From
From
Type 2 Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 280 Pages
  • Global
From
From
Type 2 Diabetes Market 2026-2030 - Product Thumbnail Image

Type 2 Diabetes Market 2026-2030

  • Report
  • April 2026
  • 305 Pages
  • Global
From
Type 2 Diabetes (T2D): Epidemiology Report and Forecast - Product Thumbnail Image

Type 2 Diabetes (T2D): Epidemiology Report and Forecast

  • Report
  • July 2026
  • 56 Pages
  • Global
From
From
From
From
From
Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Diabetes Therapeutics and Diagnostics

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Endocrinology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Endocrinology Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
Loading Indicator

The Antidiabetic market is a subset of Endocrine and Metabolic Disorders Drugs, which are used to treat a variety of conditions related to hormones and metabolism. Antidiabetic drugs are used to treat diabetes, a chronic condition in which the body does not produce or properly use insulin. These drugs can help control blood sugar levels, reduce the risk of complications, and improve quality of life. Common antidiabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, and meglitinides. Some companies in the Antidiabetic market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. These companies produce a variety of antidiabetic drugs, including insulin, oral medications, and combination products. Show Less Read more